{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T21:58:50Z","timestamp":1775944730682,"version":"3.50.1"},"reference-count":21,"publisher":"Informa UK Limited","issue":"12","license":[{"start":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T00:00:00Z","timestamp":1636329600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001254","name":"Ipsen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001254","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Expert Review of Clinical Pharmacology"],"published-print":{"date-parts":[[2021,12,2]]},"DOI":"10.1080\/17512433.2021.1986004","type":"journal-article","created":{"date-parts":[[2021,10,21]],"date-time":"2021-10-21T01:27:08Z","timestamp":1634779628000},"page":"1551-1560","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":11,"title":["Pharmacological and safety profile of a prolonged-release lanreotide formulation in acromegaly"],"prefix":"10.1080","volume":"14","author":[{"given":"Sebastian","family":"Neggers","sequence":"first","affiliation":[{"name":"Medicine and Endocrinology, Erasmus University Medical Center, Erasmus University Rotterdam, Rotterdam, Netherlands"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Corin","family":"Badiu","sequence":"additional","affiliation":[{"name":"Department of Endocrinology National Institute of Endocrinology, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8837-4343","authenticated-orcid":false,"given":"Betina","family":"Biagetti","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, Hospital Universitari Vall d\u2019Hebron, Barcelona, Spain"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucie","family":"Durand-Gasselin","sequence":"additional","affiliation":[{"name":"Clinical Pharmacokinetics & Pharmacometrics, Ipsen Innovation, Les Ulis, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Petit","sequence":"additional","affiliation":[{"name":"Drug Product Development & Industrialization, Ipsen PharmSciences, Dreux, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Petrossians","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital of Li\u00e8ge, Sart Tilman Campus, Li\u00e8ge, Belgium"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Regnault","sequence":"additional","affiliation":[{"name":"Ipsen, Boulogne-Billancourt, France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Rich","sequence":"additional","affiliation":[{"name":"Global Development, Rare Diseases, Ipsen BioInnovation, Abingdon, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zulfiya","family":"Shafigullina","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, North-Western State Medical University Named after I.I Mechnikov, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergey","family":"Shustov","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, North-Western State Medical University Named after I.I Mechnikov, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Vydrych","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, North-Western State Medical University Named after I.I Mechnikov, St. Petersburg, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,11,8]]},"reference":[{"key":"cit0001","doi-asserted-by":"publisher","DOI":"10.1007\/s11102-016-0765-7"},{"key":"cit0002","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-018-0058-5"},{"key":"cit0003","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2013-3318"},{"key":"cit0004","doi-asserted-by":"publisher","DOI":"10.4158\/EP.17.S4.1"},{"key":"cit0005","doi-asserted-by":"publisher","DOI":"10.2147\/PPA.S20783"},{"key":"cit0006","unstructured":"Somatuline\u00ae LA 30 mg. Summary of product characteristics. 2019 Dec 17 [cited 2021 Jun 25]. Available from: https:\/\/www.medicines.org.uk\/emc\/product\/965\/smpc"},{"key":"cit0007","unstructured":"Somatuline\u00ae autogel\u00ae. Summary of product characteristics. 2021 Jul 6 [cited 2021 Oct 11]. Available from: https:\/\/www.medicines.org.uk\/emc\/medicine\/25104"},{"key":"cit0008","doi-asserted-by":"publisher","DOI":"10.4172\/clinical-practice.1000386"},{"key":"cit0009","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-1042"},{"key":"cit0010","first-page":"79","volume":"2012","author":"Gomez-Panzani E","year":"2012","journal-title":"Res Rep Endocr Disord"},{"key":"cit0011","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-15-0215"},{"key":"cit0012","doi-asserted-by":"publisher","DOI":"10.1055\/s-0030-1267244"},{"key":"cit0013","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-020-02424-z"},{"key":"cit0014","doi-asserted-by":"publisher","DOI":"10.1055\/a-1247-4713"},{"key":"cit0015","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-020-09588-z"},{"key":"cit0016","doi-asserted-by":"publisher","DOI":"10.1177\/0091270011399761"},{"key":"cit0017","doi-asserted-by":"publisher","DOI":"10.2165\/0003088-200948010-00004"},{"key":"cit0018","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2005.02372.x"},{"key":"cit0019","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1994.tb03941.x"},{"key":"cit0020","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1994.tb04344.x"},{"key":"cit0021","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2005.04.014"}],"container-title":["Expert Review of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/17512433.2021.1986004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,23]],"date-time":"2022-06-23T07:07:39Z","timestamp":1655968059000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1080\/17512433.2021.1986004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":21,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12,2]]}},"alternative-id":["10.1080\/17512433.2021.1986004"],"URL":"https:\/\/doi.org\/10.1080\/17512433.2021.1986004","relation":{},"ISSN":["1751-2433","1751-2441"],"issn-type":[{"value":"1751-2433","type":"print"},{"value":"1751-2441","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,8]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ierj20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2021-02-17","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-09-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-08","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}